Christopher Mirabelli Leap Therapeutics, Inc. (LPTX) insider trading activity

LPTX Quotes by TradingView

Christopher Mirabelli is Director of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 21,626 shares of LPTX, which is worth approximately $44,333. The most recent transaction as insider was on Dec 23, 2025, when has been sold 712 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.6K
3.4% 3M change
325.21% 12M change
Total Value Held $44,333

Christopher Mirabelli Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2025
BUY
Other acquisition or disposition
-
712 Added 3.19%
21,626 Common Stock
Mar 28 2025
SELL
Payment of exercise price or tax liability
$2,135 $0.32 p/Share
6,672 Reduced 24.19%
20,914 Common Stock
Mar 28 2025
BUY
Exercise of conversion of derivative security
-
22,500 Added 44.92%
27,586 Common Stock
Jan 26 2024
BUY
Exercise of conversion of derivative security
-
5,000 Added 49.57%
5,086 Common Stock
CM

Christopher Mirabelli

Director
Cambridge, MA

Track Institutional and Insider Activities on LPTX

Follow LEAP THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LPTX shares.

Notify only if

Insider Trading

Get notified when an Leap Therapeutics, Inc. insider buys or sells LPTX shares.

Notify only if

News

Receive news related to LEAP THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LPTX